Prostate cancer is the second-leading cause of death in men in the U.S., affecting one in eight men during their lifetimes, emphasizing the need for improved detection methods.
The study's rigorous design included over 2,100 patients across diverse racial and ethnic backgrounds, allowing for accurate subgroup analysis to validate the effectiveness of the Stockholm3 test.
Collection
[
|
...
]